Orient Pharma Co., Ltd.(TW:4166)
NT$22.55+0.05 (+0.22%)
TW:4166
Orient Pharma Co., Ltd. financials statements
NT$22.55
At close:+0.05 (+0.22%)
Orient Pharma Co., Ltd. (4166) Income Statement
Orient Pharma Co., Ltd. Income Statement
Last quarter (Q2 2026), Orient Pharma Co., Ltd.'s total revenue was NT$427.08M, an increase of 31.19% from the same quarter last year. In Q2, Orient Pharma Co., Ltd.'s net income was NT$57.44M. See Orient Pharma Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.40B | NT$ 1.22B | NT$ 889.91M | NT$ 511.86M | NT$ 463.34M | |
| NT$ 706.92M | NT$ 651.56M | NT$ 468.67M | NT$ 155.35M | NT$ 142.67M | |
| NT$ 445.86M | NT$ 493.64M | NT$ 444.35M | NT$ 197.09M | NT$ 276.16M | |
| Depreciation and Amortization | NT$ 135.61M | NT$ 135.72M | NT$ 135.57M | NT$ 69.10M | NT$ 65.18M |
| NT$ 396.67M | NT$ 312.81M | NT$ 172.40M | NT$ 35.37M | NT$ -39.21M | |
| NT$ 261.06M | NT$ 157.91M | NT$ 27.75M | NT$ -33.73M | NT$ -104.39M | |
| NT$ -16.41M | NT$ 5.21M | NT$ -4.83M | NT$ 629.00K | NT$ 23.40M | |
| NT$ 244.65M | NT$ 163.12M | NT$ 22.92M | NT$ -41.11M | NT$ -110.09M | |
| NT$ 208.44M | NT$ 107.37M | NT$ 22.29M | NT$ -28.76M | NT$ -102.65M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.90 | NT$ 0.48 | NT$ 0.10 | NT$ -0.15 | NT$ -0.55 |
| Diluted EPS | NT$ 0.90 | NT$ 0.48 | NT$ 0.10 | NT$ -0.15 | NT$ -0.55 |
| Weighted Average Shares Outstanding | 231.60M | 223.03M | 223.03M | 187.00M | 187.01M |
| Weighted Average Shares Outstanding (Diluted) | 231.60M | 223.70M | 223.03M | 187.00M | 187.01M |
Currency in TWD
